THERAPEUTIC AGENT FOR SPINOCEREBELLAR DEGENERACY CONTAINING PDE INHIBITOR AS EFFECTIVE INGREDIENT

摘要

PROBLEM TO BE SOLVED: To provide a pharmacotherapy by developing new curing mechanism relating to ataxia together with spinocerebellar degeneracy. SOLUTION: New method for treating spinocerebellar degeneracy is provided by administering cGMP-PDE inhibitor, and thereby improvements of ataxia together with spinocerebellar degeneracy can be shown.